一种新型超高剂量率质子治疗技术:点扫描质子弧治疗联合FLASH(SPLASH)
研究在开源质子计划平台MatRad中实现SPLASH优化框架,基于剂量分布与剂量平均剂量率优化临床剂量体积约束,依次最小化单点跳数权重和加速器束流限制,实现首个基于体素的FLASH剂量率动态弧治疗。用脑、肝、前列腺三个代表性病例测试,比较IMPT、SPArc与SPLASH的剂量体积直方图、剂量率体积直方图和剂量率图,结果显示SPLASH在靶区与感兴趣区的V40 Gy/s较SPArc和IMPT显著提高,且每点最优束流在现有质子机器研究版规格内(<200 nA)。
要点
- SPLASH实现首个基于体素的超高剂量率与高剂量适形质子束治疗。
- 在全部测试病例中,SPLASH的靶区与感兴趣区V40 Gy/s较SPArc和IMPT显著提高。
- 每点最优束流同时生成,处于现有质子机器研究版规格内(<200 nA)。
核心结论
- SPLASH提供了首个基于体素的超高剂量率且高剂量适形的质子束治疗。
- 该技术有潜力满足广泛疾病部位的需求,并无需应用患者特异性脊形过滤器即可简化临床工作流程,此前从未被证实。
研究设计与样本
- SPLASH框架在开源质子计划平台MatRad(德国癌症研究中心放射肿瘤医学物理系)中实现。
- 优化基于剂量分布与剂量平均剂量率,依次最小化单点权重上的跳数约束和加速器束流,实现首个基于体素的FLASH剂量率动态弧治疗。
- 新优化框架最小化结合计划质量与基于体素剂量率约束的总代价函数值。
- 采用脑、肝、前列腺癌三个代表性病例进行测试。
主要发现
- SPLASH/SPArc在剂量适形性方面较IMPT提供更优的计划质量。
- 剂量率体积直方图结果表明,与SPArc和IMPT相比,SPLASH在全部测试病例中显著提高靶区和感兴趣区的V40 Gy/s。
- 每点最优束流同时生成,处于现有质子机器研究版规格内(<200 nA)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To take full advantage of FLASH dose rate (40 Gy/s) and high-dose conformity, we introduce a novel optimization and delivery technique, the spot-scanning proton arc therapy (SPArc) + FLASH (SPLASH). METHODS AND MATERIALS: SPLASH framework was implemented in an open-source proton planning platform (MatRad, Department of Medical Physics in Radiation Oncology, German Cancer Research Center). It optimizes with the clinical dose-volume constraint based on dose distribution and the dose-average dose rate by minimizing the monitor unit constraint on spot weight and accelerator beam current sequentially, enabling the first dynamic arc therapy with voxel-based FLASH dose rate. This new optimization framework minimizes the overall cost function value combined with plan quality and voxel-based dose-rate constraints. Three representative cases (brain, liver, and prostate cancer) were used for testing purposes. Dose-volume histogram, dose-rate-volume histogram, and dose-rate map were compared among intensity modulated proton radiation therapy (IMPT), SPArc, and SPLASH. RESULTS: SPLASH/SPArc could offer superior plan quality over IMPT in terms of dose conformity. The dose-rate-volume histogram results indicated SPLASH could significantly improve V40 Gy/s in the target and region of interest for all tested cases compared with SPArc and IMPT. The optimal beam current per spot is simultaneously generated, which is within the existing proton machine specifications in the research version (<200 nA). CONCLUSIONS: SPLASH offers the first voxel-based ultradose-rate and high-dose conformity treatment using proton beam therapy. Such a technique has the potential to fit the needs of a broad range of disease sites and simplify clinical workflow without applying a patient-specific ridge filter, which has never before been demonstrated.
引用
- Liu G, Zhao L, Li X, et al. A Novel Ultrahigh-Dose-Rate Proton Therapy Technology: Spot-Scanning Proton Arc Therapy + FLASH (SPLASH). Int J Radiat Oncol Biol Phys. 2023. PMID: 37196836. doi:10.1016/j.ijrobp.2023.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。